{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer", "Chemotherapy", "Food/Herbal drug interactions", "Herbal medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36750849", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "09"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "07"}], "Language": ["eng"], "ELocationID": ["41", "10.1186/s12906-023-03869-1"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "07"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses.", "Pagination": {"StartPage": "41", "MedlinePgn": "41"}, "Abstract": {"AbstractText": ["The concurrent usage of herbal medicines with conventional therapies is an important concern in cancer treatment which can lead to unexpected consequences like herb-drug interactions. This study aimed to determine the prevalence of potential herb-drug interactions and to predict factors associated with herb-drug interactions for cancer patients.", "This cross-sectional study was conducted among a convenience sample of 315 cancer patients referring to the oncology clinics of Kerman city in 2018. Data were collected via comprehensive face-to-face interviews and medical chart reviews. A drug interaction checker was used to determine herb-drug interactions. The information of patients was compared based on herb-drug interactions using bivariable logistic regression models, and predictors were determined by the multivariable logistic regression model. All analyses were performed by Stata software version 16.", "Of 262 patients (83.2% of the patients) who used herbal medicines, 209 patients [79.8% (95% Confidence Intervals (CI): 75.2 - 85.1)] had potential herb-drug interactions. Chamomile was the most popular herbal medicine (n\u2009=\u2009163, 78.0%), and minor and moderate herb-drug interactions were caused by green tea (n\u2009=\u200934, 16.3%) and peppermint (n\u2009=\u200978, 37.5%). The number of chemotherapeutic agents (OR: 1.92, 95% CI: 1.43-2.58; P-value\u2009<\u20090.0001) and the experienced of pain during chemotherapy courses (OR\u2009=\u20092.22, 95%CI:1.00-4.94; P-value\u2009=\u20090.04) were some of the predictors of herb-drug interactions among cancer patients.", "Herbal medicine use during chemotherapy was found prevalent among cancer patients; of them, the experience of potential herb-drug interactions was highly frequent. Oncologists and clinical pharmacologists are recommended to take into account challenges associated with herb-drug interactions in their routine practices, particularly during chemotherapy among these patients."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616914111, Iran."}], "LastName": "Bazrafshani", "ForeName": "Maliheh Sadat", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran. drpardakhti@yahoo.com."}], "LastName": "Pardakhty", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Hematology and Oncology Division, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Kalantari Khandani", "ForeName": "Behjat", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Tajadini", "ForeName": "Haleh", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Ghazanfari Pour", "ForeName": "Sadra", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departement of Medical Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Hashemi", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Amiri", "ForeName": "Shiva", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616914111, Iran."}], "LastName": "Mehmandoost", "ForeName": "Soheil", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sirjan School of Medical Sciences, Sirjan, Iran."}], "LastName": "Beigzadeh", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616914111, Iran."}], "LastName": "Abbaszadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616914111, Iran. sharifihami@gmail.com."}], "LastName": "Sharifi", "ForeName": "Hamid", "Initials": "H"}], "GrantList": [{"GrantID": "95000567", "Agency": "Kerman University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Iran"}, {"QualifierName": [], "DescriptorName": "Prevalence"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Watson CJ. The ever-expanding landscape of cancer therapeutic approaches. FEBS J. 288:6082-6086. 10.1111/febs.16228.", "ArticleIdList": ["34719877"]}, {"Citation": "WHO cancer regional profile . World Health Organization. 2020."}, {"Citation": "Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47(3):309\u2013316.", "ArticleIdList": ["PMC5971166", "29845017"]}, {"Citation": "Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363\u201385. doi: 10.3322/caac.21565.", "ArticleIdList": ["10.3322/caac.21565", "31184787"]}, {"Citation": "Hauner K, Maisch P, Retz M. Side effects of chemotherapy. Der Urologe Ausg A. 2017;56(4):472\u2013479. doi: 10.1007/s00120-017-0338-z.", "ArticleIdList": ["10.1007/s00120-017-0338-z", "28251254"]}, {"Citation": "Hsu H, Tsai S, Wu S, Jeang S, Ho M, Liou W, et al. Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer. Support Care Cancer. 2017;25(11):3457\u20133464. doi: 10.1007/s00520-017-3768-7.", "ArticleIdList": ["10.1007/s00520-017-3768-7", "28634657"]}, {"Citation": "Abdalla MEAH, Ali AM, Loong L. The use of complementary and alternative medicine (CAM) among cancer patients at a tertiary hospital in Malaysia. Complement Ther Med. 2020;50:102343. doi: 10.1016/j.ctim.2020.102343.", "ArticleIdList": ["10.1016/j.ctim.2020.102343", "32444037"]}, {"Citation": "Greener M. The hidden problem of herb-drug interactions. Prescriber. 2016;27(9):22\u201327. doi: 10.1002/psb.1496.", "ArticleIdList": ["10.1002/psb.1496"]}, {"Citation": "Asiimwe JB, Nagendrappa PB, Atukunda EC, Kamatenesi MM, Nambozi G, Tolo CU, et al. Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2021;2021:9963038. doi: 10.1155/2021/9963038.", "ArticleIdList": ["10.1155/2021/9963038", "PMC8149249", "34055029"]}, {"Citation": "Ong\u2019udi M, Mutai P, Weru I. Study of the use of complementary and alternative medicine by cancer patients at Kenyatta National Hospital, Nairobi Kenya. J Oncol Pharm Pract. 2019;25(4):918\u201328. doi: 10.1177/1078155218805543.", "ArticleIdList": ["10.1177/1078155218805543", "30319064"]}, {"Citation": "Cheng CW, Fan W, Ko SG, Song L, Bian ZX. Evidence-based management of herb-drug interaction in cancer chemotherapy. Explore. 2010;6(5):324\u2013329. doi: 10.1016/j.explore.2010.06.004.", "ArticleIdList": ["10.1016/j.explore.2010.06.004", "20832765"]}, {"Citation": "Engdal S, Steinsbekk A, Klepp O, Nilsen OG. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer. 2008;16(7):763\u2013769. doi: 10.1007/s00520-007-0371-3.", "ArticleIdList": ["10.1007/s00520-007-0371-3", "18196289"]}, {"Citation": "Ramos-Esquivel A, V\u00edquez-Jaikel \u00c1, Fern\u00e1ndez C. Potential drug-drug and herb-drug interactions in patients with cancer: a prospective study of medication surveillance. J Oncol Pract. 2017;13(7):e613\u2013e622. doi: 10.1200/JOP.2017.020859.", "ArticleIdList": ["10.1200/JOP.2017.020859", "28628392"]}, {"Citation": "Awortwe C, Makiwane M, Reuter H, Muller C, Louw J, Rosenkranz B. Critical evaluation of causality assessment of herb\u2013drug interactions in patients. Br J Clin Pharmacol. 2018;84(4):679\u2013693. doi: 10.1111/bcp.13490.", "ArticleIdList": ["10.1111/bcp.13490", "PMC5867089", "29363155"]}, {"Citation": "Alsanad SM, Howard RL, Williamson EM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med. 2016;16(1):1\u20139. doi: 10.1186/s12906-016-1372-x.", "ArticleIdList": ["10.1186/s12906-016-1372-x", "PMC5070090", "27756298"]}, {"Citation": "Fasinu PS, Rapp GK. Herbal interaction with chemotherapeutic drugs\u2014a focus on clinically significant findings. Front Oncol. 2019;9:1356. doi: 10.3389/fonc.2019.01356.", "ArticleIdList": ["10.3389/fonc.2019.01356", "PMC6901834", "31850232"]}, {"Citation": "Bazrafshani MS, Khandani BK, Pardakhty A, Tajadini H, Malek Pour Afshar R, Moazed V, et al. The prevalence and predictors of using herbal medicines among Iranian cancer patients. Complement Ther Clin Pract. 2019;35:368\u201373. doi: 10.1016/j.ctcp.2019.03.009.", "ArticleIdList": ["10.1016/j.ctcp.2019.03.009", "31003684"]}, {"Citation": "Soherwardi S, Chogtu B, Faizal P. Surveillance of the Potential Drug-Drug Interactions in the Medicine Department of a Tertiary Care Hospital. J Clin Diagn Res. 2012;6(7):1258-61."}, {"Citation": "Wolf CP, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, et al. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. J Cancer Res Clin Oncol. 2022;148(5):1123\u20131135. doi: 10.1007/s00432-021-03675-7.", "ArticleIdList": ["10.1007/s00432-021-03675-7", "PMC9016053", "34228225"]}, {"Citation": "Azizah N, Halimah E, Puspitasari IM, Hasanah AN. Simultaneous use of herbal medicines and antihypertensive drugs among hypertensive patients in the community: a review. J Multidiscip Healthc. 2021;14:259. doi: 10.2147/JMDH.S289156.", "ArticleIdList": ["10.2147/JMDH.S289156", "PMC7868580", "33568913"]}, {"Citation": "McIntyre E, Saliba AJ, Wiener KK, Sarris J. Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study. BMC Complement Altern Med. 2016;16(1):1\u201312. doi: 10.1186/s12906-016-1022-3.", "ArticleIdList": ["10.1186/s12906-016-1022-3", "PMC4750248", "26865257"]}, {"Citation": "Hughes GD, Aboyade OM, Beauclair R, Mbamalu ON, Puoane TR. Characterizing herbal medicine use for noncommunicable diseases in urban South Africa. Evid based Complement Alternat Med. 2015;2015:736074. doi: 10.1155/2015/736074.", "ArticleIdList": ["10.1155/2015/736074", "PMC4629029", "26557865"]}, {"Citation": "Routledge PA, Bracchi R. Adverse drug reactions to herbal medicines. Adverse Drug Reaction Bulletin. 2021;331(1):1283\u20131286. doi: 10.1097/FAD.0000000000000058.", "ArticleIdList": ["10.1097/FAD.0000000000000058"]}, {"Citation": "Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(1):1\u20139. doi: 10.1186/s12906-018-2160-6.", "ArticleIdList": ["10.1186/s12906-018-2160-6", "PMC5855977", "29544493"]}, {"Citation": "Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb\u2013drug interactions. Front Pharmacol. 2012;3:69. doi: 10.3389/fphar.2012.00069.", "ArticleIdList": ["10.3389/fphar.2012.00069", "PMC3339338", "22557968"]}, {"Citation": "Parvez MK, Rishi V. Herb-drug interactions and hepatotoxicity. Curr Drug Metab. 2019;20(4):275\u2013282. doi: 10.2174/1389200220666190325141422.", "ArticleIdList": ["10.2174/1389200220666190325141422", "30914020"]}, {"Citation": "Mahmoud D. The Prevalence of Clinically Relevant Herb-Drug Interactions between Herbal Products and Anti-Cancer Therapy in Older Adults with Cancer. 2021."}, {"Citation": "Van Leeuwen R, Brundel D, Neef C, van Gelder T, Mathijssen R, Burger D, et al. Prevalence of potential drug\u2013drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer. 2013;108(5):1071\u20131078. doi: 10.1038/bjc.2013.48.", "ArticleIdList": ["10.1038/bjc.2013.48", "PMC3619066", "23412102"]}, {"Citation": "Engdal S, Klepp O, Nilsen OG. Identification and exploration of herb-drug combinations used by cancer patients. Integr Cancer Ther. 2009;8(1):29\u201336. doi: 10.1177/1534735408330202.", "ArticleIdList": ["10.1177/1534735408330202", "19174505"]}, {"Citation": "Ganzera M, Schneider P, Stuppner H. Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes. Life Sci. 2006;78(8):856\u201361. doi: 10.1016/j.lfs.2005.05.095.", "ArticleIdList": ["10.1016/j.lfs.2005.05.095", "16137701"]}, {"Citation": "Fahim SM, Mishuk AU, Cheng N, Hansen R, Calder\u00f3n AI, Qian J. Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the US Food and Drug Administration Adverse Event Reporting System (FAERS) Expert Opin Drug Saf. 2019;18(2):145\u2013152. doi: 10.1080/14740338.2019.1562546.", "ArticleIdList": ["10.1080/14740338.2019.1562546", "30576263"]}, {"Citation": "Engdal S, Nilsen OG. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res. 2009;23(7):906\u2013912. doi: 10.1002/ptr.2750.", "ArticleIdList": ["10.1002/ptr.2750", "19170155"]}, {"Citation": "Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E. Potential drug interactions with dietary and herbal supplements during hospitalization. Intern Emerg Med. 2017;12(3):301\u2013310. doi: 10.1007/s11739-016-1548-x.", "ArticleIdList": ["10.1007/s11739-016-1548-x", "27709322"]}, {"Citation": "Chi D, Ding D, Zhao Q, Liang X, Wu W, Luo J, et al. Potential herb\u2013drug interactions in community-dwelling older adults in China: the Shanghai Aging Study. Aging Clin Exp Res. 2020;32(12):2677\u20132685. doi: 10.1007/s40520-020-01489-0.", "ArticleIdList": ["10.1007/s40520-020-01489-0", "32008224"]}, {"Citation": "Tan M, Win MT, Khan SA. The use of complementary and alternative medicine in chronic pain patients in Singapore: a single-centre study. Ann Acad Med Singapore. 2013;42(3):133\u2013137. doi: 10.47102/annals-acadmedsg.V42N3p133.", "ArticleIdList": ["10.47102/annals-acadmedsg.V42N3p133", "23604502"]}, {"Citation": "Mi T, Li X, Zhou G, Qiao S, Shen Z, Zhou YJA, et al. HIV disclosure to family members and medication adherence: role of social support and self-efficacy. AIDS Behav. 2020;24(1):45\u201354. doi: 10.1007/s10461-019-02456-1.", "ArticleIdList": ["10.1007/s10461-019-02456-1", "30863978"]}, {"Citation": "Zargaran A, Borhani-Haghighi A, Salehi-Marzijarani M, Faridi P, Daneshamouz S, Azadi A, et al. Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study. Neurol Sci. 2018;39(8):1345\u201353. doi: 10.1007/s10072-018-3415-1.", "ArticleIdList": ["10.1007/s10072-018-3415-1", "29808331"]}, {"Citation": "Mahboubi M. Mentha spicata as natural analgesia for treatment of pain in osteoarthritis patients. Complement Ther Clin Pract. 2017;26:1\u20134. doi: 10.1016/j.ctcp.2016.11.001.", "ArticleIdList": ["10.1016/j.ctcp.2016.11.001", "28107842"]}, {"Citation": "Agbabiaka TB, Spencer NH, Khanom S, Goodman C. Prevalence of drug\u2013herb and drug\u2013supplement interactions in older adults: a cross-sectional survey. Br J Gen Pract. 2018;68(675):e711\u2013e717. doi: 10.3399/bjgp18X699101.", "ArticleIdList": ["10.3399/bjgp18X699101", "PMC6145997", "30249608"]}, {"Citation": "Kargozar R, Azizi H, Salari R. A review of effective herbal medicines in controlling menopausal symptoms. Electron Physician. 2017;9(11):5826. doi: 10.19082/5826.", "ArticleIdList": ["10.19082/5826", "PMC5783135", "29403626"]}, {"Citation": "Pietrzy\u0144ski \u0141, Pysz-Waberski D, Pietrzy\u0144ska T, Kliber M, Gisterek I. Prevalence of complementary and alternative therapy use by patients with advanced and metastatic cancer. Palliative Medicine in Practice. 2022;16(2):108\u2013116. doi: 10.5603/PMPI.2022.0008.", "ArticleIdList": ["10.5603/PMPI.2022.0008"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "30"}, {"Year": "2023", "Month": "1", "Day": "31"}, {"Year": "2023", "Month": "2", "Day": "8", "Hour": "0", "Minute": "12"}, {"Year": "2023", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["36750849", "PMC9903537", "10.1186/s12906-023-03869-1", "10.1186/s12906-023-03869-1"]}}], "PubmedBookArticle": []}